Helga Radner

6.0k total citations
69 papers, 2.4k citations indexed

About

Helga Radner is a scholar working on Rheumatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Helga Radner has authored 69 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Rheumatology, 13 papers in Epidemiology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Helga Radner's work include Rheumatoid Arthritis Research and Therapies (45 papers), Systemic Lupus Erythematosus Research (18 papers) and Lymphoma Diagnosis and Treatment (11 papers). Helga Radner is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (45 papers), Systemic Lupus Erythematosus Research (18 papers) and Lymphoma Diagnosis and Treatment (11 papers). Helga Radner collaborates with scholars based in Austria, United States and Netherlands. Helga Radner's co-authors include Daniel Aletaha, Josef S Smolen, Daniel H. Solomon, Josef S Smolen, Paul Studenic, Kazuki Yoshida, D. Aletaha, Josef S Smolen, Tuhina Neogi and Neil A. Accortt and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Annals of the Rheumatic Diseases and European Journal of Immunology.

In The Last Decade

Helga Radner

65 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helga Radner Austria 26 1.7k 543 416 292 287 69 2.4k
Carlo Alberto Scirè Italy 32 2.1k 1.2× 670 1.2× 477 1.1× 245 0.8× 333 1.2× 137 3.1k
Philippe Gaudin France 32 2.3k 1.3× 829 1.5× 644 1.5× 220 0.8× 408 1.4× 148 3.4k
Bryant R. England United States 27 1.5k 0.9× 369 0.7× 389 0.9× 392 1.3× 348 1.2× 129 2.8k
Andrew J.K. Östör United Kingdom 31 1.9k 1.1× 898 1.7× 982 2.4× 607 2.1× 390 1.4× 131 3.8k
Mitsumasa Kishimoto Japan 28 1.8k 1.1× 803 1.5× 1.1k 2.6× 186 0.6× 177 0.6× 162 2.9k
Markku Korpela Finland 34 2.7k 1.6× 693 1.3× 679 1.6× 326 1.1× 572 2.0× 86 4.0k
A. Weel Netherlands 26 1.2k 0.7× 372 0.7× 409 1.0× 327 1.1× 569 2.0× 93 4.0k
Ennio Giulio Favalli Italy 34 2.2k 1.3× 864 1.6× 915 2.2× 219 0.8× 234 0.8× 138 3.5k
Camilla Bengtsson Sweden 28 2.4k 1.4× 409 0.8× 592 1.4× 254 0.9× 346 1.2× 52 3.3k
Alexandre Sepriano Portugal 22 1.9k 1.1× 544 1.0× 813 2.0× 111 0.4× 160 0.6× 92 2.4k

Countries citing papers authored by Helga Radner

Since Specialization
Citations

This map shows the geographic impact of Helga Radner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helga Radner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helga Radner more than expected).

Fields of papers citing papers by Helga Radner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helga Radner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helga Radner. The network helps show where Helga Radner may publish in the future.

Co-authorship network of co-authors of Helga Radner

This figure shows the co-authorship network connecting the top 25 collaborators of Helga Radner. A scholar is included among the top collaborators of Helga Radner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helga Radner. Helga Radner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alten, Rieke, Juan Carlos Nieto‐González, Peggy Jacques, et al.. (2024). What benefit–risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment. RMD Open. 10(1). e003311–e003311.
2.
Araújo, Ricardo Azevedo, Elsa F Mateus, Helga Radner, et al.. (2024). COTIDIANA Dataset – Smartphone-Collected Data on the Mobility, Finger Dexterity, and Mental Health of People With Rheumatic and Musculoskeletal Diseases. IEEE Journal of Biomedical and Health Informatics. 28(11). 6538–6547.
3.
Tobudic, Selma, Elisabeth Simader, Felix Kartnig, et al.. (2023). The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination. Frontiers in Medicine. 10. 1049157–1049157. 5 indexed citations
4.
Radner, Helga. (2023). Viewpoint: how to measure comorbidities in patients with rheumatoid arthritis – clinical and academic value. Lara D. Veeken. 62(SI3). SI282–SI285. 1 indexed citations
5.
Bonelli, Michael, Helga Radner, Andreas Kerschbaumer, et al.. (2022). Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial. Annals of the Rheumatic Diseases. 81(6). 838–844. 61 indexed citations
6.
Schaardenburg, Dirkjan van, Maarten Boers, Diederik De Cock, et al.. (2018). Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts.. PubMed. 36(3). 362–370. 4 indexed citations
7.
Nikiphorou, Elena, Helga Radner, Katerina Chatzidionysiou, et al.. (2016). Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature. Arthritis Research & Therapy. 18(1). 251–251. 187 indexed citations
8.
Radner, Helga. (2016). Multimorbidity in rheumatic conditions. Wiener klinische Wochenschrift. 128(21-22). 786–790. 30 indexed citations
9.
Radner, Helga, Kazuki Yoshida, Maria D. Mjaavatten, et al.. (2015). Development of a multimorbidity index: Impact on quality of life using a rheumatoid arthritis cohort. Seminars in Arthritis and Rheumatism. 45(2). 167–173. 47 indexed citations
10.
Radner, Helga, Kazuki Yoshida, Ihsane Hmamouchi, et al.. (2015). Treatment Patterns of Multimorbid Patients with Rheumatoid Arthritis: Results from an International Cross-sectional Study. The Journal of Rheumatology. 42(7). 1099–1104. 39 indexed citations
11.
Mjaavatten, Maria D., Helga Radner, Kazuki Yoshida, et al.. (2014). Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugs. Seminars in Arthritis and Rheumatism. 44(4). 399–404. 3 indexed citations
12.
Radner, Helga, Kazuki Yoshida, Josef S Smolen, & Daniel H. Solomon. (2014). Multimorbidity and rheumatic conditions—enhancing the concept of comorbidity. Nature Reviews Rheumatology. 10(4). 252–256. 98 indexed citations
13.
Mandl, Péter, Gabriela Supp, Gábor Baksa, et al.. (2014). Relationship between radiographic joint space narrowing, sonographic cartilage thickness and anatomy in rheumatoid arthritis and control joints. Annals of the Rheumatic Diseases. 74(11). 2022–2027. 32 indexed citations
14.
Radner, Helga, Tuhina Neogi, Josef S Smolen, & Daniel Aletaha. (2013). Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review. Annals of the Rheumatic Diseases. 73(1). 114–123. 111 indexed citations
15.
Böhler, Christoph, Helga Radner, Josef S Smolen, & Daniel Aletaha. (2012). Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis. Annals of the Rheumatic Diseases. 72(2). 241–244. 40 indexed citations
16.
Böhler, Christoph, et al.. (2012). Rheumatoid arthritis and falls: the influence of disease activity. Lara D. Veeken. 51(11). 2051–2057. 55 indexed citations
17.
Ramiro, S., et al.. (2012). Combination Therapy for Pain Management in Inflammatory Arthritis: A Cochrane Systematic Review. PubMed. 90(0). 47–55. 15 indexed citations
18.
Suwannalai, Parawee, Lotte A van de Stadt, Helga Radner, et al.. (2011). Avidity maturation of ACPA in rheumatoid arthritis.. Data Archiving and Networked Services (DANS). 1 indexed citations
19.
Trembleau, Sylvie, Markus Hoffmann, Brigitte Meyer, et al.. (2010). Immunodominant T‐cell epitopes of hnRNP‐A2 associated with disease activity in patients with rheumatoid arthritis. European Journal of Immunology. 40(6). 1795–1808. 18 indexed citations
20.
Radner, Helga, et al.. (2010). Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Lara D. Veeken. 50(2). 381–388. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlo Alberto Scirè Breakdown of academic impact, for papers by Philippe Gaudin Breakdown of academic impact, for papers by Bryant R. England Breakdown of academic impact, for papers by Andrew J.K. Östör Breakdown of academic impact, for papers by Mitsumasa Kishimoto Breakdown of academic impact, for papers by Markku Korpela Breakdown of academic impact, for papers by A. Weel Breakdown of academic impact, for papers by Ennio Giulio Favalli Breakdown of academic impact, for papers by Camilla Bengtsson Breakdown of academic impact, for papers by Alexandre Sepriano
Rankless by CCL
2026